FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

398704000: Product containing bendroflumethiazide and nadolol (medicinal product)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1766623015 Nadolol+bendroflumethiazide (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
1778222012 Nadolol+bendroflumethiazide en Synonym Inactive Only initial character case insensitive SNOMED CT core module
2477023017 Bendroflumethiazide + nadolol en Synonym Inactive Entire term case insensitive SNOMED CT core module
2693810013 Bendroflumethiazide + Nadolol en Synonym Inactive Only initial character case insensitive SNOMED CT core module
3288226012 Bendroflumethiazide + nadolol (product) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3503291017 Product containing bendroflumethiazide and nadolol (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3503292012 Bendroflumethiazide and nadolol en Synonym Inactive Entire term case insensitive SNOMED CT core module
3503293019 Product containing bendroflumethiazide and nadolol en Synonym Inactive Entire term case insensitive SNOMED CT core module
3666808012 Bendroflumethiazide and nadolol product en Synonym Inactive Entire term case insensitive SNOMED CT core module
3713419013 Bendroflumethiazide- and nadolol-containing product en Synonym Active Entire term case insensitive SNOMED CT core module
59565101000001111 Nadolol +Bendroflumethiazide en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom Edition module
95385901000001118 Nadolol + Bendroflumethiazide en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom Edition module


7 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing bendroflumethiazide and nadolol Is a Product containing bendroflumethiazide true Inferred relationship Existential restriction modifier
Product containing bendroflumethiazide and nadolol Is a Nadolol+diuretic false Inferred relationship Existential restriction modifier
Product containing bendroflumethiazide and nadolol Has active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier 2
Product containing bendroflumethiazide and nadolol Has active ingredient Nadolol true Inferred relationship Existential restriction modifier 1
Product containing bendroflumethiazide and nadolol Is a Product containing nadolol true Inferred relationship Existential restriction modifier
Product containing bendroflumethiazide and nadolol Plays role Diuretic therapeutic role true Inferred relationship Existential restriction modifier
Product containing bendroflumethiazide and nadolol Is a Virtual therapeutic moiety false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet Is a False Product containing bendroflumethiazide and nadolol Inferred relationship Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet Is a False Product containing bendroflumethiazide and nadolol Inferred relationship Existential restriction modifier
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) Is a True Product containing bendroflumethiazide and nadolol Inferred relationship Existential restriction modifier
Nadolol + Bendroflumethiazide Is a True Product containing bendroflumethiazide and nadolol Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start